Christopher Ackerley is listed as an executive officer and director on 12 SEC Form D filings by 4 issuers between Jul 2009 and May 2026: LIMEADE INC (Bellevue, WA — industry reported as "Other" — 2009–2010; $25M reported sold to 45 investors), Solius Labs, Inc. (Bainbridge Island, WA — other health care — 2018–2026; $23.5M reported sold to 23 investors), Plum TV, Inc. (Bridgehampton, NY — industry reported as "Other" — 2010–2011; $6.79M reported sold to 20 investors) and Seattle Hotel Group LLC (Bellevue, WA — lodging and conventions — 2020–2024).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $55.3M sold in total.
Listed alongside Cary Woods (4 shared filings), Emily Scott (4 shared filings), Jeffrey Stewart (4 shared filings), Jonathan Kraft (4 shared filings), Thomas Scott (4 shared filings) and 31 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 12 public filings for Christopher Ackerley and found 14 differences, 3 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.